Treatment of Intraventricular Hemorrhage (IVH) by Injection of Recombinant Tissue-type Plasminogen Activator (rtPA)and#8211;Single Institution Experiences with 80 Patients
grade and age >70 years were statistically significant for poor outcome. Conclusion: Intraventricular application of rt-PA as a minimal invasive treatment modality seems to be suitable for clearance

